Remicade


Also found in: Dictionary, Medical, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for Remicade

a monoclonal antibody (trade name Remicade) used to treat Crohn's disease and rheumatoid arthritis

an anti-TNF compound (trade name Remicade) consisting of an antibody directed against TNF

References in periodicals archive ?
The company manufactures Remicade, a therapy that combats Crohn's disease and rheumatoid arthritis.
notes that over 400,000 patients have been treated with Remicade since its approval nearly five years ago by the Food and Drug Administration.
the company said that CHMPs recommendation of Flixabi was based on Phase 1 and Phase 3 clinical studies that tested the biosimilarity of Flixabi compared to Remicade on a total of 584 randomized patients with moderate to severe rheumatoid arthritis.
6,284,471 ('471) relating to REMICADE (infliximab) .
This indication further solidifies the role Remicade plays in the treatment of Crohn's disease, particularly among those struggling with fistulas," comments Jerome Boscia, vice president of clinical research and development for Centocor, which has exclusive marketing rights for Remicade in the United States.
Remicade, Enbrel and Humira are all administered via injection.
In China, Remicade is not included in the current NRDL (National Reimbursement Drugs List) although it is included in select PRDLs (Provincial Reimbursement Drugs List), and, currently, one year treatment of CD with Remicade costs around $14,000 (in U.
Samsung Bioepis, a joint venture between Samsung Biologics and Biogen Idec, has submitted a marketing authorisation application seeking approval for its Remicade (Infliximab) biosimilar candidate, SB2 to the European Medicines Agency, it was reported yesterday.
Amgen is also anticipating a psoriasis indication for Enbrel, as are J&J for Remicade and Genentech for Raptiva.
However, because many MCOs already cover Janssen Biotech's Remicade and Abbott's Humira on tier 2, emerging therapies will face challenges obtaining preferential coverage.
The major European markets can finally benefit from the availability of Inflectra following the patent expiry of reference product Remicade (infliximab).
Meanwhile, Johnson & Johnson is boosting its sales operation to maintain its market-leading role for Remicade, an RA treatment that has been available since 1999.
Johnson & Johnson's Remicade has garnered strength amid Enbrel's paltry production levels.
Clinical data and the opinions of interviewed thought leaders indicate that key current and emerging therapies have no advantage on this attribute over Janssen Biotech/Merck/Mitsubishi Tanabe's Remicade, the sales leading agent for Crohn's disease.
The company got its final marketing and manufacturing approval in India for a generic version of the rheumatoid arthritis drug, Remicade.